Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: May 22, 2026

Isolation, Enrichment, and Maintenance of Medulloblastoma Stem Cells
06:32

Isolation, Enrichment, and Maintenance of Medulloblastoma Stem Cells

Published on: September 1, 2010

Medulloblastoma.

Katja von Hoff1, Stefan Rutkowski

  • 1Department of Pediatric Hematology and Oncology, University Medical Center Hamburg-Eppendorf, Martinistr. 52, 20246, Hamburg, Germany.

Current Treatment Options in Neurology
|May 25, 2012
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Paediatric therapeutic development workshop on medulloblastoma.

British journal of cancer·2026
Same author

Therapy and biomarker dependent progression-free survival in infant sonic hedgehog medulloblastoma: a multi-national retrospective cohort study.

EClinicalMedicine·2026
Same author

Avoiding Cisplatin-Related Hearing Loss, Including Implementing Sodium Thiosulfate as Otoprotectant Into Daily Pediatric Clinical Practice: Proceedings Based on Evidence and Expert Opinion From the Ototoxicity Taskforce of the SIOP Supportive Care Network.

Ear and hearing·2026
Same author

Prevalence of diabetes mellitus in long-term cancer survivors treated with craniospinal irradiation.

Journal of the Endocrine Society·2026
Same author

Incomplete tumor resection, central neuroradiological review, and second surgery in pediatric patients with intracranial ependymoma treated in the E-HIT2000 trial.

Journal of neurosurgery. Pediatrics·2026
Same author

<i>hTERT</i> Expression, Regulation, and Prognostic Significance in Pediatric Medulloblastoma.

bioRxiv : the preprint server for biology·2026

Effective medulloblastoma treatment requires interdisciplinary collaboration, maximal safe surgery, and tailored risk stratification. Radiotherapy is avoided in young children with specific subtypes, while others receive intensified chemotherapy and radiation protocols.

Area of Science:

  • Pediatric Oncology
  • Neurosurgery
  • Radiation Oncology

Background:

  • Medulloblastoma treatment necessitates a multidisciplinary approach involving diagnosis, treatment, and aftercare.
  • Maximal safe surgical resection is the critical first step, followed by comprehensive staging.
  • Expertise in neurosurgery, histopathology, and neuroradiology is crucial for accurate assessment and risk stratification.

Purpose of the Study:

  • To outline current best practices and evolving strategies for medulloblastoma management.
  • To emphasize the importance of risk-adapted therapy based on histopathological and radiological findings.
  • To highlight the need for quality control in radiotherapy and comprehensive long-term follow-up.

Main Methods:

  • Maximal safe surgical resection followed by thorough staging.

More Related Videos

Intracranial Orthotopic Allografting of Medulloblastoma Cells in Immunocompromised Mice
05:10

Intracranial Orthotopic Allografting of Medulloblastoma Cells in Immunocompromised Mice

Published on: October 3, 2010

Related Experiment Videos

Last Updated: May 22, 2026

Isolation, Enrichment, and Maintenance of Medulloblastoma Stem Cells
06:32

Isolation, Enrichment, and Maintenance of Medulloblastoma Stem Cells

Published on: September 1, 2010

Intracranial Orthotopic Allografting of Medulloblastoma Cells in Immunocompromised Mice
05:10

Intracranial Orthotopic Allografting of Medulloblastoma Cells in Immunocompromised Mice

Published on: October 3, 2010

  • Histopathological and neuroradiological assessments for risk stratification.
  • Age- and risk-specific treatment protocols including surgery, chemotherapy, and radiotherapy (craniospinal irradiation - CSI).
  • Central review of pathology and staging evaluations.
  • Inclusion in prospective studies for ongoing research and targeted therapy development.

    • Main Results:

    • Avoidance of craniospinal radiotherapy in young children with desmoplastic/nodular medulloblastoma (DMB) or extensive nodular medulloblastoma.
    • Investigation of optimized strategies (high-dose chemotherapy, stem cell rescue) for young children with classic medulloblastoma (CMB), large cell, or anaplastic medulloblastoma (LC/A MB).
    • Standard therapy for standard-risk patients involves craniospinal radiotherapy (23.4 Gy CSI, 54 Gy boost) followed by maintenance chemotherapy.
    • Intensified treatment (higher dose CSI, 36-Gy or 40-Gy) for high-risk patients (LC/A MB, metastatic, large residual tumor).

    Conclusions:

    • High-quality interdisciplinary collaboration is paramount for successful medulloblastoma treatment.
    • Risk stratification and tailored treatment strategies, including judicious use of radiotherapy and chemotherapy, are essential.
    • Ongoing research, quality control, and comprehensive long-term follow-up are vital for improving outcomes and developing targeted therapies.